Release Date: 21/06/19 12:22 Summary: Voluntary Administrators Supplementary Report to Creditors Price Sensitive: No Download Document 167.19KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%